Ursprung des Netzwerks ersten Grades von Sudha Rao
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia.
3
| Holding Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sudha Rao
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Compliance Officer | |
| Manhattan College | College/University | Undergraduate Degree | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ANU Connect Ventures Pty Ltd.
 ANU Connect Ventures Pty Ltd. Investment ManagersFinance ANU Connect Ventures Pty Ltd (ANU Connect Ventures) is a venture capital subsidiary of Australian National University founded in 2005. The firm is headquartered in Canberra, Australia. | Investment Managers | Private Equity Investor | |
| ADALTA LIMITED | Biotechnology | Director/Board Member | |
| Pace Law School | College/University | Graduate Degree | |
Beta Therapeutics Pty Ltd.
 Beta Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Beta Therapeutics Pty Ltd. develops new diabetes therapeutics based on key discoveries. It generates preventative and potentially curative therapies for the people who suffer from diabetes. The company was founded by Keats Nelms, Chris Parish and Charmaine Simeonovic in 2011 and is headquartered in Canberra, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
| RACE ONCOLOGY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BlueSphere Bio, Inc.
 BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 6 |
| Australien | 6 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Health Services | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| General Counsel | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Private Equity Investor | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Keir Loiacono | 6 |
| David Fuller | 4 |
| Jeremy Chrisp | 3 |
